相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Neutrophils in cancer, a love-hate affair
Daniela Cerezo-Wallis et al.
FEBS JOURNAL (2022)
Tumor-associated myeloid cells: diversity and therapeutic targeting
Alberto Mantovani et al.
CELLULAR & MOLECULAR IMMUNOLOGY (2021)
Mesenchymal Stem Cells Successfully Deliver Oncolytic Virotherapy to Diffuse Intrinsic Pontine Glioma
Michael Chastkofsky et al.
CLINICAL CANCER RESEARCH (2021)
ONCR-177, an Oncolytic HSV-1 Designed to Potently Activate Systemic Antitumor Immunity
Brian B. Haines et al.
CANCER IMMUNOLOGY RESEARCH (2021)
Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
Hyuna Sung et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2021)
Systemic Delivery of Oncolytic Adenovirus to Tumors Using Tumor-Infiltrating Lymphocytes as Carriers
Joao Santos et al.
CELLS (2021)
MDSC in Mice and Men: Mechanisms of Immunosuppression in Cancer
Christophe Vanhaver et al.
JOURNAL OF CLINICAL MEDICINE (2021)
Tumor-Associated Macrophages: A Potential Target for Cancer Therapy
Yifan Tan et al.
FRONTIERS IN ONCOLOGY (2021)
Primary HPV-based cervical cancer screening in Europe: implementation status, challenges, and future plans
P. J. Maver et al.
CLINICAL MICROBIOLOGY AND INFECTION (2020)
Checkpoint inhibitor immunotherapy in kidney cancer
Wenxin Xu et al.
NATURE REVIEWS UROLOGY (2020)
Mesenchymal stem cells as carriers for systemic delivery of oncolytic viruses
Agata Hadrys et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2020)
Engineering vaccinia virus as an immunotherapeutic battleship to overcome tumor heterogeneity
Adrian Pelin et al.
EXPERT OPINION ON BIOLOGICAL THERAPY (2020)
Engineering and combining oncolytic measles virus for cancer therapy
Mathias F. Leber et al.
CYTOKINE & GROWTH FACTOR REVIEWS (2020)
Neural Stem Cells Improve the Delivery of Oncolytic Chimeric Orthopoxvirus in a Metastatic Ovarian Cancer Model
Mohamed Hammad et al.
MOLECULAR THERAPY-ONCOLYTICS (2020)
Oncolytic Activity of a Novel Influenza A Virus Carrying Granulocyte-Macrophage Colony-Stimulating Factor in Hepatocellular Carcinoma
Yang Penghui et al.
HUMAN GENE THERAPY (2019)
Perspectives on immunotherapy via oncolytic viruses
Alberto Reale et al.
INFECTIOUS AGENTS AND CANCER (2019)
Enhanced Safety and Efficacy of Oncolytic VSV Therapy by Combination with T Cell Receptor Transgenic T Cells as Carriers
Michael Karl Melzer et al.
MOLECULAR THERAPY-ONCOLYTICS (2019)
Durvalumab With or Without Tremelimumab for Patients With Metastatic Pancreatic Ductal Adenocarcinoma: A Phase 2 Randomized Clinical Trial
Eileen M. O'Reilly et al.
JAMA ONCOLOGY (2019)
Oncolytic Maraba virus armed with tumor antigen boosts vaccine priming and reveals diverse therapeutic response patterns when combined with checkpoint blockade in ovarian cancer
A. J. Robert McGray et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2019)
Systemic Therapy for Locally Advanced and Metastatic Non-Small Cell Lung Cancer A Review
Kathryn C. Arbour et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2019)
Arming oncolytic reovirus with GM-CSF gene to enhance immunity
Vera Kemp et al.
CANCER GENE THERAPY (2019)
Intravenous Injections of a Rationally Selected Oncolytic Herpes Virus as a Potent Virotherapy for Hepatocellular Carcinoma
Yong Luo et al.
MOLECULAR THERAPY-ONCOLYTICS (2019)
A Comparative Safety Profile Assessment of Oncolytic Virus Therapy Based on Clinical Trials
Takuma Matsuda et al.
THERAPEUTIC INNOVATION & REGULATORY SCIENCE (2018)
Oncolytic Viruses as Antigen-Agnostic Cancer Vaccines
Stephen J. Russell et al.
CANCER CELL (2018)
Talimogene laherparepvec: First in class oncolytic virotherapy
Robert M. Conry et al.
HUMAN VACCINES & IMMUNOTHERAPEUTICS (2018)
Antibody-Neutralized Reovirus Is Effective in Oncolytic Virotherapy
Robert A. Berkeley et al.
CANCER IMMUNOLOGY RESEARCH (2018)
Oncolytic VSV Primes Differential Responses to Immuno-oncology Therapy
Nicholas M. Durham et al.
MOLECULAR THERAPY (2017)
Colorectal cancer screening: An updated review of the available options
Iyad A. Issa et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2017)
Global Cancer Incidence and Mortality Rates and Trends-An Update
Lindsey A. Torre et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2016)
Breast Cancer Screening and Prevention
Ann B. Nattinger et al.
ANNALS OF INTERNAL MEDICINE (2016)
Patterns of Clinical Response with Talimogene Laherparepvec (T-VEC) in Patients with Melanoma Treated in the OPTiM Phase III Clinical Trial
Robert H. I. Andtbacka et al.
ANNALS OF SURGICAL ONCOLOGY (2016)
Oncolytic virus therapy: A new era of cancer treatment at dawn
Hiroshi Fukuhara et al.
CANCER SCIENCE (2016)
Oncolytic viruses: a new class of immunotherapy drugs
Howard L. Kaufman et al.
NATURE REVIEWS DRUG DISCOVERY (2015)
Combined Nivolumab and Ipilimumab or Monotherapy in Untreated Melanoma
J. Larkin et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
T cell exclusion, immune privilege, and the tumor microenvironment
Johanna A. Joyce et al.
SCIENCE (2015)
Systemic delivery of HER2-retargeted oncolytic-HSV by mesenchymal stromal cells protects from lung and brain metastases
Valerio Leoni et al.
ONCOTARGET (2015)
Analysis of glioblastoma tumor coverage by oncolytic virus-loaded neural stem cells using MRI-based tracking and histological reconstruction
R. A. Morshed et al.
CANCER GENE THERAPY (2015)
Seroprevalence of Herpes Simplex Virus Types 1 and 2-United States, 1999-2010
Heather Bradley et al.
JOURNAL OF INFECTIOUS DISEASES (2014)
Myeloid-Derived Suppressor Cells as a Vehicle for Tumor-Specific Oncolytic Viral Therapy
Samuel Eisenstein et al.
CANCER RESEARCH (2013)
Ways to enhance lymphocyte trafficking into tumors and fitness of tumor infiltrating lymphocytes
Matteo Bellone et al.
FRONTIERS IN ONCOLOGY (2013)
Antitumor efficacy of oncolytic herpes simplex virus adsorbed onto antigen-specific lymphocytes
A. Kanzaki et al.
CANCER GENE THERAPY (2012)
Evaluation of Monocytes as Carriers for Armed Oncolytic Adenoviruses in Murine and Syrian Hamster Models of Cancer
Maria Bunuales et al.
HUMAN GENE THERAPY (2012)
Targeting TNF-α to Neoangiogenic Vessels Enhances Lymphocyte Infiltration in Tumors and Increases the Therapeutic Potential of Immunotherapy
Arianna Calcinotto et al.
JOURNAL OF IMMUNOLOGY (2012)
Oncolytic virotherapy
Stephen J. Russell et al.
NATURE BIOTECHNOLOGY (2012)
Systemic Delivery of Oncolytic Viruses: Hopes and Hurdles
Mark S. Ferguson et al.
ADVANCES IN VIROLOGY (2012)
Tumor-associated macrophages infiltrate plasmacytomas and can serve as cell carriers for oncolytic measles virotherapy of disseminated myeloma
Kah-Whye Peng et al.
AMERICAN JOURNAL OF HEMATOLOGY (2009)
Comparison of intravenous versus intraperitoneal administration of oncolytic herpes simplex virus 1 for peritoneal carcinomatosis in mice
Y. Kulu et al.
CANCER GENE THERAPY (2009)
Dendritic cells and T cells deliver oncolytic reovirus for tumour killing despite pre-existing anti-viral immunity
E. J. Ilett et al.
GENE THERAPY (2009)
Cross-infection of tumor cells by contact with T lymphocytes loaded with Newcastle disease virus
Christina Pfirschke et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2009)
Loading of oncolytic vesicular stomatitis virus onto antigen-specific T cells enhances the efficacy of adoptive T-cell therapy of tumors
J. Qiao et al.
GENE THERAPY (2008)
Purging metastases in lymphoid organs using a combination of antigen-nonspecific adoptive T cell therapy, oncolytic virotherapy and immunotherapy
Jian Qiao et al.
NATURE MEDICINE (2008)
Evaluation of T cells as carriers for systemic measles virotherapy in the presence of antiviral antibodies
H. T. Ong et al.
GENE THERAPY (2007)
Tumor-targeted, systemic delivery of therapeutic viral vectors using hitchhiking on antigen-specific T cells
C Cole et al.
NATURE MEDICINE (2005)
Targeted delivery of adenoviral vectors by cytotoxic T cells
P Yotnda et al.
BLOOD (2004)
Blood clearance rates of adenovirus type 5 in mice
R Alemany et al.
JOURNAL OF GENERAL VIROLOGY (2000)
分享论文
